Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

Kistorp, Caroline, Faber, Jens, Galatius, Søren, Gustafsson, Finn, Frystyk, Jan, Flyvbjerg, Allan, Hildebrandt, Per·2005·Circulation

Cited by (606)

Items 201–300 of 606

  1. Association of Adiponectin With Left Ventricular Mass in Blacks
    Aurelian Bidulescu, Jiankang Liu, Solomon K. Musani, Ervin Ray Fox, Tandaw E. Samdarshi, Daniel F. Sarpong, Viola Vaccarino, Peter W.F. Wilson, Donna K. Arnett, Rebecca Din‐Dzietham et al. · 2011 · Circulation Heart Failure
  2. The roles of epicardial adipose tissue in heart failure
    Ying Song, Fei Song, Chan Wu, Yi‐Xiang Hong, Gang� Li · 2020 · Heart Failure Reviews
  3. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection
    Rick B. Meeker, Winona Poulton, Silva Markovic‐Plese, Colin D. Hall, Kevin Robertson · 2011 · Journal of NeuroVirology
  4. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function
    Jeetesh V. Patel, A. Abraheem, Olena Dotsenko, John Creamer, Mark Gunning, Elizabeth A. Hughes, Gregory Y.H. Lip · 2008 · Journal of Internal Medicine
  5. Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome
    Yoshihisa Okamoto · 2011 · Cardiology Research and Practice
  6. INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist
    Hugo R. Ramos, Andreas L. Birkenfeld, Adolfo J de Bold · 2015 · Endocrine Connections
  7. Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?
    Richard J. Charnigo, Maya E. Guglin · 2016 · Heart Failure Reviews
  8. The Year in Heart Failure
    W.H. Wilson Tang, Gary S. Francis · 2007 · Journal of the American College of Cardiology
  9. Association of Low Plasma Adiponectin With Early Diastolic Dysfunction
    Smita Negi, Euy-Myoung Jeong, Irfan Shukrullah, Mihai Raicu, Samuel C. Dudley · 2012 · Congestive Heart Failure
  10. Adiponectin in Chronic Kidney Disease: A Complex and Context Sensitive Clinical Situation
    Peter Stenvinkel · 2011 · Journal of Renal Nutrition
  11. Cardiomyocyte Expression and Cell-specific Processing of Procholecystokinin
    Jens Peter Goetze, Anders Holten Johnsen, Caroline Kistorp, Finn Gustafsson, Camilla Bardram Johnbeck, Jens Frederik Rehfeld · 2015 · Journal of Biological Chemistry
  12. Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome
    Ilse C. Schrieks, Anna Nozza, Barbara Elisabeth Stähli, John B. Buse, Robert R. Henry, Klas Malmberg, Bruce Charles Neal, Stephen James Nicholls, Lars Rydén, Linda Mellbin et al. · 2018 · Diabetes Care
  13. Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients
    Kristina Blaslov, Tomislav Bulum, Karin Zibar, Lea Smircic Duvnjak · 2013 · International Journal of Endocrinology
  14. Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery
    Shih‐Hsien Sung, Tao-Cheng Wu, Cheng-Hsiung Huang, S J Lin, J.-W. Chen · 2011 · Heart
  15. Relatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: Relation to sex hormone-binding globulin
    Altan Onat, Gülay Hergenç, Dursun Dursunoğlu, Zekeriya Küçükdurmaz, Serkan Bulur, Günay Can · 2008 · International Journal of Biological Sciences
  16. Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
    Julius Bogomolovas, Kathrin Brohm, Jelena Čelutkienė, Giedrė Balčiūnaitė, Daiva Bironaitė, Virginija Bukelskienė, Dainius Daunoravičus, Christian C. Witt, Jens Fielitz, Virginija Grabauskienė et al. · 2015 · BioMed Research International
  17. Novel Biomarkers in Acute Heart Failure
    Marat Yanavitski, Michael M. Givertz · 2011 · Current Heart Failure Reports
  18. Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure.
    Roberto Tarquini, Cristina Tosti Guerra, Maria Cristina Porciani, Antonio Michelucci, Margherita Padeletti, Giuseppe Ricciardi, Marco Chiostri, Sanja Jelić, Luigi Padeletti · 2009 · PubMed
  19. Pleiotropic effects of niacin: Current possibilities for its clinical use
    M. Zeman, Marek Vecka, František Perlík, Barbora Staňková, Róbert Hromádka, EVA TVRZICKÁ, Jakub Širc, Jakub Hrib, Aleš Žák · 2016 · Acta Pharmaceutica
  20. High level of plasma adiponectin in acute stroke patients is associated with stroke mortality
    Hikaru Nagasawa, Chiaki Yokota, Ḱazunori Toyoda, Atsushi Ito, Kazuo Minematsu · 2011 · Journal of the Neurological Sciences
  21. Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure
    Ou Zhang, Qingwei Ji, Yingzhong Lin, Zhijian Wang, Ying Huang, Wensheng Lu, Xiaofei Liu, Jianwei Zhang, Yuyang Liu, Yujie Zhou · 2015 · Clinica Chimica Acta
  22. Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial
    Brian A. Bergmark, Christopher Paul Cannon, William B. White, Petr Jarolı́m, Yuyin Liu, Marc P. Bonaca, Faiez M. Zannad, David A. Morrow · 2017 · Diabetes Obesity and Metabolism
  23. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease
    Gideon R. Hajer, Yolanda van der Graaf, Jobien K. Olijhoek, Michael Edlinger, Frank L.J. Visseren · 2007 · American Heart Journal
  24. Adiponectin: Saving the starved and the overfed
    C. J. Behre · 2007 · Medical Hypotheses
  25. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications
    Savoia, Carmine, Volpe, Massimo, Alonzo, Alessandro, Rossi, Chiara, Rubattu, Speranza · 2010 · Clinical Science
  26. New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy
    Deepa Mangalat Gopal, Flora Sam · 2013 · Journal of Cardiovascular Translational Research
  27. Adiponectin and cardiometabolic trait and mortality: where do we go?
    Albert Youngwoo Jang, Philipp E. Scherer, Jang‐Young Kim, Soo Kyung Lim, Kwang Kon Koh · 2021 · Cardiovascular Research
  28. Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
    Weena J.Y. Chen, Luuk J. Rijzewijk, Rutger W. van der Meer, Martijn W. Heymans, Eelco van Duinkerken, Mark Lubberink, Adriaan A. Lammertsma, Hildo J. Lamb, A. Roos, Johannes Anthonius Romijn et al. · 2011 · Cardiovascular Diabetology
  29. Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis
    Joshua F. Baker, Joan Marie Von Feldt, Sogol Mostoufi‐Moab, Woojin Kim, Elena Taratuta, Mary Beth Leonard · 2015 · The Journal of Rheumatology
  30. Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
    Ina Maria Kacsó, Cosmina Ioana Bondor, Gabriel Kacsó · 2012 · Scandinavian Journal of Clinical and Laboratory Investigation
  31. Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting
    Emiliano Angeloni, Giovanni Melina, Umberto Benedetto, Simone Refice, Fabio Capuano, Antonino Roscitano, Cosimo Comito, Riccardo Sinatra · 2011 · The Annals of Thoracic Surgery
  32. Adiponectin and All-Cause Mortality in Elderly People With Type 2 Diabetes
    Jessica R. Singer, Walter Palmas, Jeanne A. Teresi, Ruth S. Weinstock, Steven Shea, Jose Alejandro Luchsinger · 2012 · Diabetes Care
  33. The Role of Adiponectin in Maintaining Metabolic Homeostasis
    Süleyman Cem Adıyaman, Muhammet Özer, Başak Özgen Saydam, Barış Akıncı · 2019 · Current Diabetes Reviews
  34. Effect of L-arginine supplementation on insulin resistance and serum adiponectin concentration in rats with fat diet.
    Anna Miczke, Joanna Suliburska, Danuta Pupek‐Musialik, Lucyna Ostrowska, Anna Jabłecka, Zbigniew Krejpcio, Damian Skrypnik, Paweł Bogdański · 2015 · PubMed Central
  35. Use of Obesity Biomarkers in Cardiovascular Epidemiology
    Tobias Pischon · 2009 · Disease Markers
  36. Serum high‐molecular‐weight adiponectin level and incident dementia in patients with vascular risk factors
    Kazuo Kitagawa, Kaori Miwa, Shuhei Okazaki, Manabu Sakaguchi, Hideki Mochizuki · 2015 · European Journal of Neurology
  37. Preserved muscle protein metabolism in obese patients with chronic heart failure
    Roberto Aquilani, Maria Teresa La Rovere, Oreste Febo, Federica Boschi, Paolo Iadarola, Daniela Corbellini, Simona Viglio, Andria Innocenza Bongiorno, Ornella Pastoris, Manuela Verri · 2011 · International Journal of Cardiology
  38. Targeting adiponectin for cardioprotection
    Noriyuki Ouchi, Rei Shibata, Kenneth X. Walsh · 2006 · Expert Opinion on Therapeutic Targets
  39. Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
    Yuanyuan Bao, Xiliang Shang, Linuo Zhou, Renming Hu, Yiming Li, Wei Qun Ding · 2011 · Archives of Medical Science
  40. Circulating Adiponectin Levels Are Paradoxically Associated With Mortality Rate: A Systematic Review and Meta-Analysis
    Maria Giovanna Scarale, Andrea Fontana, Vincenzo Trischitta, Massimiliano Copetti, Claudia Menzaghi · 2018 · The Journal of Clinical Endocrinology & Metabolism
  41. Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload
    Karen M. O’Shea, David J. Chess, Ramzi J. Khairallah, Sharad Rastogi, Peter A. Hecker, Hani N. Sabbah, Kenneth X. Walsh, William C. Stanley · 2010 · American Journal of Physiology-Heart and Circulatory Physiology
  42. Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction
    Alexandra Zavin, Karla M. Daniels, Ross A Arena, Kelly Allsup, Antonio A. Lazzari, Jacob Joseph, Paul Christian Schulze, Stewart H. Lecker, Daniel E. Forman · 2012 · International Journal of Cardiology
  43. Exercise training reduces circulating adiponectin levels in patients with chronic heart failure
    An M. Van Berendoncks, Paul J Beckers, Vicky Y. Hoymans, Nadine M. Possemiers, Floris L. Wuyts, Christiaan J. Vrints, Viviane Marie Conraads · 2009 · Clinical Science
  44. Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
    Albin Oh, Ross A. Okazaki, Flora Sam, María Valero‐Muñoz · 2019 · Frontiers in Cardiovascular Medicine
  45. Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants
    Linda Broer, Julia Raschenberger, Joris Deelen, Massimo Mangino, Veryan Codd, Kirsi Hannele Pietiläinen, Eva Albrecht, Najaf Amin, Marian Beekman, Anton J.M. de Craen et al. · 2014 · European Journal of Epidemiology
  46. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients
    Keisuke Kawai, Seinosuke Kawashima, Toshiyuki Miyazaki, Eiichi Tajiri, Masuki Mori, Kazuhisa Kitazaki, Tomohiko Shirotani, Tetsuya Inatome, Hiroshi Yamabe, Ken‐ichi Hirata et al. · 2009 · Journal of Cardiology
  47. Adiponectin Levels Are Elevated in Patients With Pulmonary Arterial Hypertension
    Mário Santos, Abílio Reis, Fabienne Gonçalves, Manuel J. Ferreira‐Pinto, Sofia Cabral, Severo Torres, Adelino Ferreira Leite-Moreira, Tiago Henriques‐Coelho · 2013 · Clinical Cardiology
  48. Body Mass Index in Acute Heart Failure: Association with Clinical Profile, Therapeutic Management and in-Hospital Outcome
    John Parissis, Dimitrios T. Farmakis, Nikolaos P. E. Kadoglou, Ignatios Ikonomidis, Ekaterini Fountoulaki, Erifili E. Hatziagelaki, Spyridon G. Deftereos, Ferenc Folláth, Alexandre Mebazaa, John P Lekakis et al. · 2016 · European Journal of Heart Failure
  49. Nutrition intervention in heart failure: should consumption of the DASH eating pattern be recommended to improve outcomes?
    Renad Abu‐Sawwa, Sandra Barker Dunbar, Arshed Ali Quyyumi, Elisabeth Lilian Pia Sattler · 2019 · Heart Failure Reviews
  50. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction
    Yoshimasa Aso, Ruriko Suganuma, Sadao Wakabayashi, Kenji Hara, Tomoki Nakano, Mariko Suetsugu, Sachiko Matsumoto, Takafumi Nakamachi, Kohzo Takebayashi, Kimio Morita et al. · 2009 · Translational research
  51. Adiponectin and end-stage renal disease
    Anastasia G. Markaki, Emmanuel Psylinakis, Aspasia Spyridaki · 2016 · HORMONES
  52. Adiponectin: A Promising Marker for Cardiovascular Disease
    Tobias Pischon, Eric B. Rimm · 2006 · Clinical Chemistry
  53. Effect of Simvastatin vs. Rosuvastatin on Adiponectin and Haemoglobin A1c Levels in Patients with Non-Ischaemic Chronic Heart Failure
    Takayoshi Tsutamoto, Masayuki Yamaji, Chiho Kawahara, Keizo Nishiyama, Masanori Fujii, Takashi Yamamoto, Minoru Horie · 2009 · European Journal of Heart Failure
  54. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein
    Christopher D. Owens, Ji Min Kim, Nathanael D. Hevelone, Allen D. Hamdan, J.D. Raffetto, Mark A. Creager, Michael S. Conte · 2010 · Journal of Vascular Surgery
  55. Association of Body Mass Index With Cardiac Reverse Remodeling and Long-Term Outcome in Advanced Heart Failure Patients With Cardiac Resynchronization Therapy
    Chi Cai, Wei Hua, Ligang Ding, Jing Wang, Keping Chen, Xinwei Yang, Zhimin Liu, Shu Zhang · 2014 · Circulation Journal
  56. Clinical Adoption of Prognostic Biomarkers: The Case for Heart Failure
    Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Javed Butler · 2012 · Progress in Cardiovascular Diseases
  57. Biomarkers in Diagnosing and Treatment of Acute Heart Failure
    Leili Pourafkari, Arezou Tajlil, Nader D. Nader · 2019 · Biomarkers in Medicine
  58. Low HDL Levels as the Most Common Metabolic Syndrome Risk Factor in Heart Failure
    Makbule Kutlu Karadağ, Mehmet Akbulut · 2009 · International Heart Journal
  59. Effects of Chronic PPAR‐Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague‐Dawley Rats
    Eileen Blasi, Jonathan R. R. Heyen, Michelle D. Hemkens, Aileen D. McHarg, CAROLYN A. ECELBARGER, Swasti Tiwari · 2009 · PPAR Research
  60. Effects of Pitavastatin on Fasting and Postprandial Endothelial Function and Blood Rheology in Patients With Stable Coronary Artery Disease
    Kenshiro Arao, Takanori Yasu, Tomio Umemoto, Sachimi Jinbo, Nahoko Ikeda, Shinichiro Ueda, Masanobu Kawakami, Shin‐ichi Momomura · 2009 · Circulation Journal
  61. Does adiponectin resistance exist in chronic heart failure?
    Ulrich Kintscher · 2007 · European Heart Journal
  62. Hormonal consequences and prognosis of chronic heart failure
    Philipp Attanasio, Stefan D. Anker, Wolfram Doehner, Stephan von Haehling · 2011 · Current Opinion in Endocrinology Diabetes and Obesity
  63. Plasma Adiponectin Is Associated with Plasma Brain Natriuretic Peptide and Cardiac Function in Healthy Subjects
    Takahiro Ohara, Jiyoong Kim, Masanori Asakura, Hiroshi Asanuma, Satoshi Nakatani, Kazuhiko Hashimura, Hideaki Kanzaki, Tohru Funahashi, Hitonobu Tomoike, Masafumi Kitakaze · 2008 · Hypertension Research
  64. Effect of Carvedilol on Plasma Adiponectin Concentration in Patients With Chronic Heart Failure
    Masayuki Yamaji, Takayoshi Tsutamoto, Toshinari Tanaka, Chiho Kawahara, Keizo Nishiyama, Takashi Yamamoto, Masanori Fujii, Minoru Horie · 2009 · Circulation Journal
  65. Elevated adiponectin levels in patients with chronic heart failure: An independent predictor of mortality or a marker of cardiac cachexia?
    Turgay Celık, Halıl Yaman · 2009 · International Journal of Cardiology
  66. Association between High Molecular Weight Adiponectin Levels and Metabolic Parameters
    Daisuke Fujimatsu, Norihiko Kotooka, Teruo Inoue, Masanori Nishiyama, Koichi Node · 2009 · Journal of Atherosclerosis and Thrombosis
  67. High Stable Serum Adiponectin Levels Are Associated with a Better Outcome in Prevalent Dialysis Patients
    Juan José Díez, Patricia Estrada, María Auxiliadora Bajo, María José Fernández‐Reyes, Cristina Grande, Gloria del Peso, Manuel Heras, Alvaro Molina, Pedro Iglesias, Rafael Jesús Sánchez et al. · 2009 · American Journal of Nephrology
  68. Impact of Oxidative Stress on Plasma Adiponectin in Patients With Chronic Heart Failure
    Toshinari Tanaka, Takayoshi Tsutamoto, Keizo Nishiyama, Hiroshi Sakai, Masanori Fujii, Takashi Yamamoto, Minoru Horie · 2007 · Circulation Journal
  69. Functional Adiponectin Resistance and Exercise Intolerance in Heart Failure
    An M. Van Berendoncks, Viviane Marie Conraads · 2011 · Current Heart Failure Reports
  70. Biomarkers of Endothelial Dysfunction are Elevated and Related to Prognosis in Chronic Heart Failure Patients with Diabetes but not in Those Without Diabetes
    Caroline Kistorp, Aun‐Yeong Chong, Finn Gustafsson, Søren Galatius, Ilan E. Raymond, Jens Oscar Faber, Gregory Y.H. Lip, Per Rossen Hildebrandt · 2008 · European Journal of Heart Failure
  71. Adiponectin, diabetes and ischemic heart failure: a challenging relationship
    Samuele Baldasseroni, Alessandro Antenore, Claudia Di Serio, Francesco Orso, Giuseppe Lonetto, Nadia Bartoli, Alice Foschini, Andrea Giosafat Marella, Alessandra Pratesi, Salvatore Scarantino et al. · 2012 · Cardiovascular Diabetology
  72. Obesity and heart failure with preserved ejection fraction: A growing problem
    Stuart B. Prenner, Paul J. Mather · 2017 · Trends in Cardiovascular Medicine
  73. Adipokines and Their Role in Heart Failure: A Literature Review
    Saira Rafaqat · 2023 · Journal of Innovations in Cardiac Rhythm Management
  74. Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
    Qian Zhang, Chongxuan Lu, Feng Lu, Yunjun Liao, Junrong Cai, Jianhua Gao · 2024 · Frontiers in Endocrinology
  75. RETRACTED: Epicardial adipose tissue and cardiac lipotoxicity: A review
    Anirban Goutam Mukherjee, Kaviyarasi Renu, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Abhijit Dey, Balachandar Vellingiri, Raja Ganesan · 2023 · Life Sciences · Retracted
  76. Beta-blockers modify the prognostic value of adiponectin in chronic heart failure
    An M. Van Berendoncks, Paul J Beckers, Vicky Y. Hoymans, Nadine M. Possemiers, Samuel Coenen, Monique M. Elseviers, Christiaan J. Vrints, Viviane Marie Conraads · 2010 · International Journal of Cardiology
  77. Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia
    H Vaverková, David Karásek, Dalibor Novotný, Dagmar Jackuliaková, Milan Halenka, Jiří Lukeš, Jiri J Frohlich · 2007 · Atherosclerosis
  78. Association Between Epicardial Fat Thickness and Weight Homeostasis Hormones in Patients With Noncachectic Heart Failure
    George Karayannis, Grigorios Giamouzis, Nikolaos Tziolas, Panagiotis Georgoulias, John S. Skoularigis, Dimitri P. Mikhailidis, Filippos K. Triposkiadis · 2012 · Angiology
  79. Anatomy of the obesity paradox in heart failure
    Maya E. Guglin, Khyati Baxi, Matthew B. Schabath · 2013 · Heart Failure Reviews
  80. Relationship Between Serum Adiponectin Levels and Disability-Free Survival Among Community-Dwelling Elderly Individuals: The Tsurugaya Project
    Atsushi Hozawa, Y. Sugawara, Yasutake Tomata, Masako Kakizaki, Toru Tsuboya, Kaori Ohmori‐Matsuda, Naoki Nakaya, Shinichi Kuriyama, Akira Fukao, Ichiro Tsuji · 2011 · The Journals of Gerontology Series A
  81. CDH13 Genotype–Dependent Association of High–Molecular Weight Adiponectin With All-Cause Mortality: The J-SHIPP Study
    Eri Uetani, Yasuharu Tabara, Ryuichi Kawamoto, Hiroshi Onuma, Katsuhiko Kohara, Haruhiko Osawa, Tetsuro Miki · 2013 · Diabetes Care
  82. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study
    Benjamin Dieplinger, Meinhard Haltmayer, Werner Poelz, Thomas Mueller · 2009 · Clinica Chimica Acta
  83. Impact of Obesity and Bariatric Surgery on Cardiovascular Disease
    Michael A. Mathier, Ramesh Chandran Ramanathan · 2007 · Medical Clinics of North America
  84. Associations between Endothelin-1 and Adiponectin in Chronic Heart Failure
    Wei‐Hsian Yin, Yung‐Hsiang Chen, Jeng Wei, Hsu-Lung Jen, Wen-ping Huang, Mason Shing Young, Der-Cherng Chen, Po‐Len Liu · 2011 · Cardiology
  85. Differential Effect of Baseline Adiponectin on All-Cause Mortality in Hemodialysis Patients Depending on Initial Body Mass Index. Long-Term Follow-Up Data of 4.5 Years
    Christina Tsigalou, Georgios K. Chalikias, Konstantina Kantartzi, Dimitrios N. Tziakas, Georgia Kampouromiti, Vassilis A. Vargemezis, Stavros Konstantinides, Sofia Ktenidou-Kartali, Konstantinos Simopoulos, Ploumis Passadakis · 2012 · Journal of Renal Nutrition
  86. Determinants of Adiponectin Levels in Patients With Chronic Systolic Heart Failure
    Andréia Biolo, Rei Shibata, Noriyuki Ouchi, Shinji Kihara, Mina Sonoda, Kenneth X. Walsh, Flora Sam · 2010 · The American Journal of Cardiology
  87. Serum adiponectin and protein–energy wasting in predialysis chronic kidney disease
    Young Youl Hyun, Kyu‐Beck Lee, Kook‐Hwan Oh, Curie Ahn, Sue K. Park, Dong‐Wan Chae, Tae‐Hyun Yoo, Kyu Hun Cho, Yong‐Soo Kim, Young‐Hwan Hwang · 2016 · Nutrition
  88. Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome
    Elvis Teijeira‐Fernández, Sonia Eiras-Penas, Lilian Grigorian Shamagian, Antonio Salgado‐Somoza, C. Delgado, José Ramón González‐Juanatey · 2011 · Cytokine
  89. Associations of Serum Adiponectin with Skeletal Muscle Morphology and Insulin Sensitivity
    Erik Ingelsson, Johan Ärnlöv, Björn Zethelius, Ramachandran Srini Vasan, Allan Flyvbjerg, Jan Frystyk, Christian Berne, Arvo Haenni, Lars Lind, Johan Sundström · 2008 · The Journal of Clinical Endocrinology & Metabolism
  90. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: A prospective study
    Heidi Marie Christensen, Caroline Kistorp, Morten Schou, Niels Keller, Bo Zerahn, Jan Frystyk, Allan Flyvbjerg, Jens Oscar Faber · 2013 · Metabolism
  91. Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure
    Ghazaleh Gouya, P. Voithofer, Stephanie Neuhold, Angela Storka, Greisa Vila, Richard Pacher, Michael Wolzt, Martin Hülsmann · 2014 · International Journal of Clinical Practice
  92. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure
    Goran Loncar, Biljana Božić Nedeljković, Vojkan Čvorović, Zoran A. Radojicic, Siniša Dimković, Nataša Marković, Nenad Prodanović, Toplica Lepić, Biljana Putniković, Vera Popović-Brkić · 2009 · Endocrine
  93. Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study
    Jon Viljar Norvik, Henrik Schirmer, Kirsti Ytrehus, Trond Geir Jenssen, Svetlana N. Zykova, Anne Elise Eggen, Björn O. Eriksen, Marit Dahl Solbu · 2017 · BMC Cardiovascular Disorders
  94. Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
    Kazumasa Unno, Rei Shibata, Hideo Izawa, Akihiro Hirashiki, Yosuke Murase, Takashi Yamada, Masakazu Kobayashi, Akiko Noda, Kohzo Nagata, Noriyuki Ouchi et al. · 2009 · Heart
  95. Tipping the Scale
    Stephan von Haehling, Tamara B. Horwich, Gregg C. Fonarow, Stefan D. Anker · 2007 · Circulation
  96. Adiponectin, body mass index and hepatic steatosis are independently associated with IGF-I status in obese non-diabetic women
    Anca Mirela Sîrbu, S. Gologan, Tudor Arbănaş, Cătălin Copăescu, Sorina Carmen Martin, Alice Ioana Albu, Carmen Gabriela Barbu, Iuliana Pîrvulescu, Simona Vasilica Fica · 2012 · Growth Hormone & IGF Research
  97. Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease
    Gražina Urbonavičienė, Jan Frystyk, Allan Flyvbjerg, Eskild W. Henneberg, Jes Sanddal Lindholt · 2010 · Atherosclerosis
  98. Role of Adipose Tissue in Determining Muscle Mass in Patients With Chronic Kidney Disease
    Carmen Castaneda‐Sceppa, Mark J. Sarnak, Xuelei Wang, Tom Greene, Magdalena Madero, John W. Kusek, Gerald J. Beck, Joel D. Kopple, Andrew S. Levey, Vandana Menon · 2007 · Journal of Renal Nutrition
  99. Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction
    H. Christensen, Morten Schou, Jens Peter Goetze, Jens Oscar Faber, Jan Frystyk, Allan Flyvbjerg, Caroline Kistorp · 2013 · BMC Cardiovascular Disorders
  100. Prognostic Value of Circulating Adipokine Levels and Expressions of Adipokines in the Myocardium of Patients With Chronic Heart Failure
    Wei‐Hsian Yin, Jeng Wei, Wen‐Pin Huang, Jaw‐Wen Chen, Mason Shing Young, Shing‐Jong Lin · 2012 · Circulation Journal